In order to evaluate the predictive power of these DMEGs for HCC prognosis, we used a LASSO regression to determine a prognostic model for HCC based on three genes (UBD, CD5L, and CD213A2) that can modulate immune responses. This evidence concerns the gene CD5L and hepatocellular carcinoma.